Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'ANTI-CD3' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 286 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Avula, CPR; Muthukumar, AR; Zaman, K; McCarter, R; Fernandes, G
      Inhibitory effects of voluntary wheel exercise on apoptosis in splenic lymphocyte subsets of C57BL/6 mice

      JOURNAL OF APPLIED PHYSIOLOGY
    2. Trobonjaca, Z; Radosevic-Stasic, B; Crncevic, Z; Rukavina, D
      Modulatory effects of octreotide on anti-CD3 and dexamethasone-induced apoptosis of murine thymocytes

      INTERNATIONAL IMMUNOPHARMACOLOGY
    3. Pessi, T; Isolauri, E; Sutas, Y; Kankaanranta, H; Moilanen, E; Hurme, M
      Suppression of T-cell activation by Lactobacillus rhamnosus GG-degraded bovine casein

      INTERNATIONAL IMMUNOPHARMACOLOGY
    4. Tanigawa, K; Takeshita, N; Eickhoff, GA; Shimizu, K; Chang, AE
      Antitumor reactivity of lymph node cells primed in vivo with dendritic cell-based vaccines

      JOURNAL OF IMMUNOTHERAPY
    5. Lum, LG; LeFever, AV; Treisman, JS; Garlie, NK; Hanson, JP
      Immune modulation in cancer patients after adoptive transfer of anti-CD3/anti-CD28-costimulated T cells - Phase I clinical trial

      JOURNAL OF IMMUNOTHERAPY
    6. Choudhry, MA; Fazal, N; Namak, SY; Haque, F; Ravindranath, T; Sayeed, MM
      PGE(2) suppresses intestinal T cell function in thermal injury: A cause ofenhanced bacterial translocation

      SHOCK
    7. Choudhry, MA; Sir, O; Sayeed, MM
      TGF-beta abrogates TCR-mediated signaling by upregulating tyrosine phosphatases in T cells

      SHOCK
    8. Zerr, DM; Gooley, TA; Yeung, L; Huang, ML; Carpenter, P; Wade, JC; Corey, L; Anasetti, C
      Human herpesvirus 6 reactivation and encephalitis in allogeneic bone marrow transplant recipients

      CLINICAL INFECTIOUS DISEASES
    9. Tran, GT; Carter, N; He, XY; Spicer, TS; Plain, KM; Nicolls, M; Hall, BM; Hodgkinson, SJ
      Reversal of experimental allergic encephalomyelitis with non-mitogenic, non-depleting anti-CD3 mAb therapy with a preferential effect on T(h)1 cells that is augmented by IL-4

      INTERNATIONAL IMMUNOLOGY
    10. Van Praag, RME; Prins, JM; Roos, MTL; Schellekens, PTA; Ten Berge, IJM; Yong, SL; Schuitemaker, H; Eerenberg, AJM; Jurriaans, S; De Wolf, F; Fox, CH; Goudsmit, J; Miedema, F; Lange, JMA
      OKT3 and IL-2 treatment for purging of the latent HIV-1 reservoir in vivo results in selective long-lasting CD4+T cell depletion

      JOURNAL OF CLINICAL IMMUNOLOGY
    11. Kim, EJ; Cho, DH; Hwang, SY; Kim, TS
      Interleukin-2 fusion protein with anti-CD3 single-chain Fv (sFv) selectively protects T cells from dexamethasone-induced apoptosis

      VACCINE
    12. Tsiatas, ML; Gritzapis, AD; Cacoullos, NT; Papadhimitriou, SI; Baxevanis, CN; Papamichail, M
      A novel culture environment for generating mature human dentritic cells from peripheral blood CD14(+) cells

      ANTICANCER RESEARCH
    13. Hubbard, WJ; Moore, JK; Contreras, JL; Smyth, CA; Chen, ZW; Lobashevsky, AL; Nagata, K; Neville, DM; Thomas, JM
      Phenotypic and functional analysis of T-cell recovery after anti-CD3 immunotoxin treatment for tolerance induction in rhesus macaques

      HUMAN IMMUNOLOGY
    14. Kummer, U; Zengerle, U; Pischel, J; Trautmann, B; Mailhammer, R; Sidell, N
      Increased in vivo mitogenicity of anti-TCR/CD3 monoclonal antibody throughreduced interaction with Fc gamma receptors

      IMMUNOLOGY LETTERS
    15. Izeradjene, K; Quemeneur, L; Michallet, MC; Bonnefoy-Berard, N; Revillard, JP
      Mycophenolate mofetil interferes with interferon gamma production in T-cell activation models

      TRANSPLANTATION PROCEEDINGS
    16. Chau, LA; Tso, JY; Madrenas, J
      Generation of partial agonist ligands of the T-cell receptor by engineering of antibodies against CD3

      TRANSPLANTATION PROCEEDINGS
    17. Fechner, JH; Dong, YC; Hong, XN; Brunner, KG; Tsuchida, M; Neville, D; Scharff, J; Lee, F; Oberley, TD; Peters, D; Schultz, JM; Manthei, ER; Hamawy, MM; Knechtle, SJ
      Graft survival in a rhesus renal transplant model after immunotoxin-mediated T-cell depletion is enhanced by mycophenolate and steroids

      TRANSPLANTATION
    18. Hamawy, MM; Tsuchida, M; Cho, CS; Manthei, ER; Fechner, JH; Knechtle, SJ
      Immunotoxin FN18-CRM9 induces stronger T cell signaling than unconjugated monoclonal antibody FN18

      TRANSPLANTATION
    19. Chau, LA; Tso, JY; Melrose, J; Madrenas, J
      HuM291 (NUVION), a humanized Fc receptor-nonbinding antibody against CD3, anergizes peripheral blood T cells as partial agonist of the T cell receptor

      TRANSPLANTATION
    20. Tamura, T; Igarashi, O; Hino, A; Yamane, H; Aizawa, S; Kato, T; Nariuchi, H
      Impairment in the expression and activity of Fyn during differentiation ofnaive CD4(+) T cells into the Th2 subset

      JOURNAL OF IMMUNOLOGY
    21. Manzke, O; Tesch, H; Borchmann, P; Wolf, J; Lackner, K; Gossmann, A; Diehl, V; Bohlen, H
      Locoregional treatment of low-grade B-cell lymphoma with CD3 x CD19 bispecific antibodies and CD28 costimulation: I. Clinical phase I evaluation

      INTERNATIONAL JOURNAL OF CANCER
    22. Jung, G; Brandl, M; Eisner, W; Fraunberger, P; Reifenbeger, G; Schlegel, U; Wiestler, OD; Reulen, FJ; Wilmanns, W
      Local immunotherapy of glioma patients with a combination of 2 bispecific antibody fragments and resting autologous lymphocytes: Evidence for in situT-cell activation and therapeutic efficacy

      INTERNATIONAL JOURNAL OF CANCER
    23. Choi, I; De Ines, C; Kurschner, T; Cochlovius, B; Sorensen, V; Olafsen, T; Sandlie, I; Little, M
      Recombinant chimeric OKT3 scFv IgM antibodies mediate immune suppression while reducing T cell activation in vitro

      EUROPEAN JOURNAL OF IMMUNOLOGY
    24. Chatenoud, L
      Restoration of self-tolerance is a feasible approach to control ongoing beta-cell specific autoreactivity: its relevance for treatment in establisheddiabetes and islet transplantation

      DIABETOLOGIA
    25. Baker, J; Verneris, MR; Ito, M; Shizuru, JA; Negrin, RS
      Expansion of cytolytic CD8(+) natural killer T cells with limited capacityfor graft-versus-host disease induction due to interferon gamma production

      BLOOD
    26. Kanda, N; Watanabe, S
      Regulatory roles of adenylate cyclase and cyclic nucleotide phosphodiesterases 1 and 4 in interleukin-13 production by activated human T cells

      BIOCHEMICAL PHARMACOLOGY
    27. Lum, LG; Sen, M
      Activated T-cell and bispecific antibody immunotherapy for high-risk breast cancer - Bench to bedside

      ACTA HAEMATOLOGICA
    28. Tanigawa, K; Craig, RA; Stoolman, LM; Chang, AE
      Effects of tumor necrosis factor-alpha on the in vitro maturation of tumor-reactive effector T cells

      JOURNAL OF IMMUNOTHERAPY
    29. McDonald, JC
      Transplantation

      JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
    30. Maluccio, MA; Rao, J; Sharma, V; Lagman, M; Suthanthiran, M
      Dendritic cells armed with anti-CD3 mAbs reduce pulmonary metastases, prolong survival, and engender antitumor effector cells demonstrable by adoptive transfer

      ANNALS OF SURGICAL ONCOLOGY
    31. Kosuge, T; Tamura, T; Nariuchi, H; Toyoshima, S
      Effect of inhibitors of glycoprotein processing on cytokine secretion and production in anti CD3-stimulated T cells

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    32. Thomas, F; Ray, P; Thomas, JM
      Immunological tolerance as an adjunct to allogeneic tissue grafting

      MICROSURGERY
    33. Miller, RA
      Effect of aging on T lymphocyte activation

      VACCINE
    34. Katzenwadel, A; Schleer, H; Gierschner, D; Wetterauer, U; Elsasser-Beile, U
      Construction and in vivo evaluation of an anti-PSA x anti-CD3 bispecific antibody for the immunotherapy of prostate cancer

      ANTICANCER RESEARCH
    35. Wood, GW; Holladay, FP; Turner, T; Wang, YY; Chiga, M
      A pilot study of autologous cancer cell vaccination and cellular immunotherapy using anti-CD3 stimulated lymphocytes in patients with recurrent gradeIII/IV astrocytoma

      JOURNAL OF NEURO-ONCOLOGY
    36. Magnan, A; Mely, L; Prato, S; Vervloet, D; Romagne, F; Camilla, C; Necker, A; Casano, B; Montero-Jullian, F; Fert, V; Malissen, B; Bongrand, P
      Relationships between natural T cells, atopy, IgE levels, and IL-4 production

      ALLERGY
    37. Li, M; Walter, R; Torres, C; Sierra, F
      Impaired signal transduction in mitogen activated rat splenic lymphocytes during aging

      MECHANISMS OF AGEING AND DEVELOPMENT
    38. Dubey, DP; Husain, Z; Levitan, E; Zurakowski, D; Mirza, N; Younes, S; Coronell, C; Yunis, D; Yunis, EJ
      The MHC influences NK and NKT cell functions associated with immune abnormalities and lifespan

      MECHANISMS OF AGEING AND DEVELOPMENT
    39. Contreras, JL; Eckhoff, DE; Cartner, S; Bilbao, G; Ricordi, C; Neville, DM; Thomas, FT; Thomas, JM
      Long-term functional islet mass and metabolic function after xenoislet transplantation in primates

      TRANSPLANTATION
    40. Thomas, JM; Eckhoff, DE; Contreras, JL; Lobashevsky, AL; Hubbard, WJ; Moore, JK; Cook, WJ; Thomas, FT; Neville, DM
      Durable donor-specific T and B cell tolerance in rhesus macaques induced with peritransplantation anti-CD3 immunotoxin and deoxyspergualin - Absence of chronic allograft nephropathy

      TRANSPLANTATION
    41. Dehoux, JP; Talpe, S; Dewolf, N; Otsuka, M; Oike, F; Jamar, F; de la Parra, B; Latinne, D; Bazin, H; Gianello, P
      Effects on human and nonhuman primate immune response of a new rat anti-CD2 monoclonal antibody

      TRANSPLANTATION
    42. Davis, TA
      Monoclonal antibody-eased therapy of lymphoid neoplasms: What's on the horizon?

      SEMINARS IN HEMATOLOGY
    43. Bethin, KE; Vogt, SK; Muglia, LJ
      Interleukin-6 is an essential, corticotropin-releasing hormone-independentstimulator of the adrenal axis during immune system activation

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    44. Van Wauwe, J; Aerts, F; Cools, M; Deroose, F; Freyne, E; Goossens, J; Hermans, B; Lacrampe, J; Van Genechten, H; Van Gerven, F; Van Nyen, G
      Identification of R146225 as a novel, orally active inhibitor of interleukin-5 biosynthesis

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    45. Drobyski, WR; Vodanovic-Jankovic, S; Klein, J
      Adoptively transferred gamma delta T cells indirectly regulate murine graft-versus-host reactivity following donor leukocyte infusion therapy in mice

      JOURNAL OF IMMUNOLOGY
    46. Illes, Z; Kondo, T; Newcombe, J; Oka, N; Tabira, T; Yamamura, T
      Differential expression of NK T cell V alpha 24J alpha Q invariant TCR chain in the lesions of multiple sclerosis and chronic inflammatory demyelinating polyneuropathy

      JOURNAL OF IMMUNOLOGY
    47. Elbe-Burger, A; Mommaas, AM; Prieschl, EE; Fiebiger, E; Baumruker, T; Stingl, G
      Major histocompatibility complex class II- fetal skin dendritic cells are potent accessory cells of polyclonal T-cell responses

      IMMUNOLOGY
    48. Gysemans, G; Waer, M; Laureys, J; Depovere, J; Pipeleers, D; Bouillon, R; Mathieu, C
      Islet xenograft destruction in the hu-PBL-severe combined immunodeficient (SCID) mouse necessitates anti-CD3 preactivation of human immune cells

      CLINICAL AND EXPERIMENTAL IMMUNOLOGY
    49. Sakuma, S; Kato, Y; Nishigaki, F; Sasakawa, T; Magari, K; Miyata, S; Ohkubo, Y; Goto, T
      FK506 potently inhibits T cell activation induced TNF-alpha and IL-1 beta production in vitvo by human peripheral blood mononuclear cells

      BRITISH JOURNAL OF PHARMACOLOGY
    50. Hasko, G; Kuhel, DG; Salzman, AL; Szabo, C
      ATP suppression of interleukin-12 and tumour necrosis factor-alpha releasefrom macrophages

      BRITISH JOURNAL OF PHARMACOLOGY
    51. Sadanaga, N; Nagoshi, M; Lederer, JA; Joo, HG; Eberlein, TJ; Goedegebuure, PS
      Local secretion of IFN-gamma induces an antitumor response: Comparison between T cells plus IL-2 and IFN-gamma transfected tumor cells

      JOURNAL OF IMMUNOTHERAPY
    52. Li, Q; Furman, SA; Bradford, CR; Chang, AE
      Expanded tumor-reactive CD4(+) T-cell responses to human cancers induced by secondary anti-CD3/anti-CD28 activation

      CLINICAL CANCER RESEARCH
    53. Fujimiya, Y; Suzuki, Y; Katakura, R; Ohno, T
      Injury to autologous normal tissues and tumors mediated by lymphokine-activated killer (LAK) cells generated in vitro from peripheral blood mononuclear cells of glioblastoma patients

      JOURNAL OF HEMATOTHERAPY
    54. Stohl, W; Hamilton, AS; Deapen, DM; Mack, TM; Horwitz, DA
      Impaired cytotoxic T lymphocyte activity in systemic lupus erythematosus following in vitro polyclonal T cell stimulation: a contributory role for non-T cells

      LUPUS
    55. Sameshima, S; Sakai, K; Nagawa, H; Tsuno, N; Kitayama, J; Muto, T
      Correlation of the therapeutic effect of activated tumor-draining lymph node cells with specific interferon-gamma production in vitro

      SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY
    56. Havelkova, H; Kosarova, M; Krulova, M; Demant, P; Lipoldova, M
      T-cell proliferative response is controlled by loci Tria4 and Tria5 on mouse Chromosomes 7 and 9

      MAMMALIAN GENOME
    57. Mollet, L; Fautrel, B; Leblond, V; Bergeron, F; Merle-Beral, H; Baumelou, E; Hubert, P; Debre, P; Autran, B
      Leukemic CD3(+) LGL share functional properties with their CD8(+)CD57(+) cell counterpart expanded after BMT

      LEUKEMIA
    58. Snapper, SB; Rosen, FS
      The Wiskott-Aldrich syndrome protein (WASP): Roles in signaling and cytoskeletal organization

      ANNUAL REVIEW OF IMMUNOLOGY
    59. Wakikawa, A; Utsuyama, M; Wakabayashi, A; Kitagawa, M; Hirokawa, K
      Age-related alteration of cytokine production profile by T cell subsets inmice: A flow cytometric study

      EXPERIMENTAL GERONTOLOGY
    60. Baxevanis, CN; Spanakos, G; Voutsas, IF; Gritzapis, AD; Tsitsilonis, OE; Mamalaki, A; Papamichail, M
      Increased generation of autologous tumor-reactive lymphocytes by anti-CD3 monoclonal antibody and prothymosin alpha

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    61. Prins, JM; Jurriaans, S; van Praag, RME; Blaak, H; van Rij, R; Schellekens, PTA; ten Berge, IJM; Yong, SL; Fox, CH; Roos, MTL; de Wolf, F; Goudsmit, J; Schuitemaker, H; Lange, JMA
      Immune-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapy

      AIDS
    62. Klingbeil, C; Hsu, DH
      Pharmacology and safety assessment of humanized monoclonal antibodies for therapeutic use

      TOXICOLOGIC PATHOLOGY
    63. Gillett, NA; Chan, CM
      Molecular pathology in the preclinical development of biopharmaceuticals

      TOXICOLOGIC PATHOLOGY
    64. Plautz, GE; Bukowski, RM; Novick, AC; Klein, EA; Kursh, ED; Olencki, TE; Yetman, RJ; Pienkny, A; Sandstrom, K; Shu, SY
      T-cell adoptive immunotherapy of metastatic renal cell carcinoma

      UROLOGY
    65. Chakravarti, B; Abraham, GN
      Aging and T-cell-mediated immunity

      MECHANISMS OF AGEING AND DEVELOPMENT
    66. Herbelin, A; Abramowicz, D; de Groote, D; Naret, C; Kreis, H; Bach, JF; Goldman, M; Chatenoud, L
      CD3 antibody-induced IL-10 in renal allograft recipients - An in vivo and in vitro analysis

      TRANSPLANTATION
    67. Wood, RFM; Pockley, AG
      Bioengineered monoclonals - Easier on patients, but still hard on rejection

      TRANSPLANTATION
    68. Friend, PJ; Hale, G; Chatenoud, L; Rebello, P; Bradley, J; Thiru, S; Phillips, JM; Waldmann, H
      Phase I study of an engineered aglycosylated humanized CD3 antibody in renal transplant rejection

      TRANSPLANTATION
    69. Thomas, FT; Ricordi, C; Contreras, JL; Hubbard, WJ; Jiang, XL; Eckhoff, DE; Cartner, S; Bilbao, G; Neville, DM; Thomas, JM
      Reversal of naturally occurring diabetes in primates by unmodified islet xenografts without chronic immunosuppression

      TRANSPLANTATION
    70. Punch, JD; Lin, J; Bluestone, J; Bromberg, JS
      CD2 and CD3 receptor-mediated tolerance - Constraints on T cell activation

      TRANSPLANTATION
    71. GROSSEHOVEST L; BRANDL M; DOHLSTEN M; KALLAND T; WILMANNS W; JUNG G
      TUMOR-GROWTH INHIBITION WITH BISPECIFIC ANTIBODY FRAGMENTS IN A SYNGENEIC MOUSE MELANOMA MODEL - THE ROLE OF TARGETED T-CELL CO-STIMULATIONVIACD28

      International journal of cancer
    72. Manzke, O; Berthold, F; Huebel, K; Tesch, H; Diehl, V; Bohlen, H
      CD3xCD19 bispecific antibodies and CD28 bivalent antibodies enhance T-cellreactivity against autologous leukemic cells in pediatric B-all bone marrow

      INTERNATIONAL JOURNAL OF CANCER
    73. Uchiyama, H; Kong, YY; Kishihara, K; Sugimachi, K; Nomoto, K
      Approach to withdrawal from tacrolimus in a fully allogeneic murine skin graft model

      IMMUNOLOGY
    74. Yanagihara, Y; Shiozawa, K; Takai, M; Kyogoku, M; Shiozawa, S
      Natural killer (NK) T cells are significantly decreased in the peripheral blood of patients with rheumatoid arthritis (RA)

      CLINICAL AND EXPERIMENTAL IMMUNOLOGY
    75. Hirohata, S
      Human Th1 responses driven by IL-12 are associated with enhanced expression of CD40 ligand

      CLINICAL AND EXPERIMENTAL IMMUNOLOGY
    76. Cullen, CM; Jameson, SC; DeLay, M; Cottrell, C; Becken, ET; Choi, E; Hirsch, R
      A divalent major histocompatibility complex/IgG1 fusion protein induces antigen-specific T cell activation in vitro and in vivo

      CELLULAR IMMUNOLOGY
    77. Koumarianou, AA; Hudson, M; Williams, R; Epenetos, AA; Stamp, GWH
      Development of a novel bi-specific monoclonal antibody approach for tumourtargeting

      BRITISH JOURNAL OF CANCER
    78. Souness, JE; Houghton, C; Sardar, N; Withnall, MT
      Suppression of anti-CD3-induced interleukin-4 and interleukin-5 release from splenocytes of Mesocestoides corti-infected BALB/c mice by phosphodiesterase 4 inhibitors

      BIOCHEMICAL PHARMACOLOGY
    79. Le Moine, O; Louis, H; Sermon, F; Goldman, M; Deviere, J
      Interleukin-10 and liver diseases

      ACTA GASTRO-ENTEROLOGICA BELGICA
    80. HOSKIN DW; WILLIAMS B; FITZPATRICK L; MAKRIGIANNIS AP
      CELL BIOLOGY AND POSSIBLE THERAPEUTIC APPLICATIONS OF ANTI-CD3-ACTIVATED KILLER T-CELLS (REVIEW)

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    81. VANAMAN SE; WHISLER RL
      DIFFERENTIAL EXPRESSION OF P53 TUMOR-SUPPRESSOR PROTEIN AND IL-2 IN ACTIVATED T-CELLS FROM ELDERLY HUMANS

      Journal of interferon & cytokine research
    82. DEVRIESVANDERZWAN A; BESSELING AC; VANDERPOL MA; DEWAAL LP; BOOG CJP
      SPECIFIC TOLERANCE INDUCTION AND ORGAN-TRANSPLANTATION

      Leukemia & lymphoma
    83. FISCHER KD; KONG YY; NISHINA H; TEDFORD K; MARENGERE LEM; KOZIERADZKI I; SASAKI T; STARR M; CHAN G; GARDENER S; NGHIEM MP; BOUCHARD D; BARBACID M; BERNSTEIN A; PENNINGER JM
      VAV IS A REGULATOR OF CYTOSKELETAL REORGANIZATION MEDIATED BY THE T-CELL RECEPTOR

      Current biology
    84. MATSUI K; ARAI T
      SALMONELLA INFECTION-INDUCED NONRESPONSIVENESS OF MURINE SPLENIC T-LYMPHOCYTES TO INTERLEUKIN-2 (IL-2) INVOLVES INHIBITION OF IL-2 RECEPTOR-GAMMA CHAIN EXPRESSION

      FEMS immunology and medical microbiology
    85. Matsui, K; Nagano, K; Arai, T; Hirono, I; Aoki, T
      DNA sequencing of the gene encoding Salmonella typhimurium-derived T-cell inhibitor (STI) and characterization of the gene product, cloned STI

      FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY
    86. BENAMOR A; SCHNEIDER E; ARNOULD A; MACHAVOINE F; DY M
      FAS CROSS-LINKING MIMICS THE INHIBITORY EFFECT OF ANTI-CD3 ON IL-3-INDUCED HISTAMINE AND CYTOKINE PRODUCTION BY MURINE MYELOID SPLEEN-CELL PRECURSORS

      Experimental hematology
    87. HOSKIN DW; TAYLOR RM; MAKRIGIANNIS AP; JAMES H; LEE TDG
      DOSE-DEPENDENT ENHANCING AND INHIBITORY EFFECTS OF A77-1726 (LEFLUNOMIDE) ON CYTOTOXIC T-LYMPHOCYTE INDUCTION

      International journal of immunopharmacology
    88. CLEMENTS DJ; MATVEYEVA M; MCCOY KL
      DELTA(9)-TETRAHYDROCANNABINOL SUPPRESSES MACROPHAGE COSTIMULATION BY DECREASING HEAT-STABLE ANTIGEN EXPRESSION

      International journal of immunopharmacology
    89. ITO O; HARADA M; TAKENOYAMA M; TAMADA K; LI TL; ABE K; FUJIE H; NOMOTO K
      VACCINATION WITH ACTIVATED B-CELLS PULSED WITH TUMOR-LYSATES CAN INDUCE TUMOR-SPECIFIC CD4(-CELLS IN-VIVO() T)

      Immunobiology
    90. KROESEN BJ; HELFRICH W; MOLEMA G; DELEIJ L
      BISPECIFIC ANTIBODIES FOR TREATMENT OF CANCER IN EXPERIMENTAL ANIMAL-MODELS AND MAN

      Advanced drug delivery reviews
    91. VANDERPOL WL; VANDEWINKEL JGJ
      IGG RECEPTOR POLYMORPHISMS - RISK-FACTORS FOR DISEASE

      Immunogenetics (New York)
    92. Lee, CA; Lawrence, BP; Kerkvliet, NI; Rifkind, AB
      2,3,7,8-tetrachlorodibenzo-p-dioxin induction of cytochrome p450-dependentarachidonic acid metabolism in mouse liver microsomes: Evidence for species-specific differences in responses

      TOXICOLOGY AND APPLIED PHARMACOLOGY
    93. STOHL W; LYNCH DH; STARLING GC; KIENER PA
      SUPERANTIGEN-DRIVEN, CD8(-CELL-MEDIATED DOWN-REGULATION - CD95 (FAS)-DEPENDENT DOWN-REGULATION OF HUMAN IG RESPONSES DESPITE CD95-INDEPENDENT KILLING OF ACTIVATED B-CELLS() T)

      The Journal of immunology (1950)
    94. KAGAMU H; SHU SY
      PURIFICATION OF L-SELECTIN(LOW) CELLS PROMOTES THE GENERATION OF HIGHLY POTENT CD4 ANTITUMOR EFFECTOR T-LYMPHOCYTES

      The Journal of immunology
    95. FERNANDEZSESMA A; PELUSO RW; BAI X; SCHULMAN JL; LEVY DE; MORAN TM
      SUPERANTIGEN-ACTIVATED T-CELLS REDIRECTED BY A BISPECIFIC ANTIBODY INHIBIT VESICULAR STOMATITIS-VIRUS REPLICATION IN-VITRO AND IN-VIVO

      The Journal of immunology
    96. NAGOSHI M; GOEDEGEBUURE PS; BURGER UL; SADANAGA N; CHANG MP; EBERLEIN TJ
      SUCCESSFUL ADOPTIVE CELLULAR IMMUNOTHERAPY IS DEPENDENT ON INDUCTION OF A HOST IMMUNE-RESPONSE TRIGGERED BY CYTOKINE (IFN-GAMMA AND GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR) PRODUCING DONOR TUMOR-INFILTRATING LYMPHOCYTES/

      The Journal of immunology
    97. YANG Y; CHANG JF; PARNES JR; FATHMAN CG
      T-CELL RECEPTOR (TCR) ENGAGEMENT LEADS TO ACTIVATION-INDUCED SPLICINGOF TUMOR-NECROSIS-FACTOR (TNF) NUCLEAR PRE-MESSENGER-RNA

      The Journal of experimental medicine
    98. RIEDLE S; ROSEL M; ZOLLER M
      IN-VIVO ACTIVATION AND EXPANSION OF T-CELLS BY A BI-SPECIFIC ANTIBODYABOLISHES METASTASIS FORMATION OF HUMAN-MELANOMA CELLS IN SCID MICE

      International journal of cancer
    99. YANG H; PARKHOUSE RME
      DIFFERENTIAL ACTIVATION REQUIREMENTS ASSOCIATED WITH STIMULATION OF T-CELLS VIA DIFFERENT EPITOPES OF CD3

      Immunology
    100. MAURICE MM; VANDERVOORT EAM; LEOW A; LEVARHT N; BREEDVELD FC; VERWEIJ CL
      CD28 CO-STIMULATION IS INTACT AND CONTRIBUTES TO PROLONGED EX-VIVO SURVIVAL OF HYPORESPONSIVE SYNOVIAL-FLUID T-CELLS IN RHEUMATOID-ARTHRITIS

      European Journal of Immunology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 03/08/20 alle ore 15:31:45